Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Other Working Capital Changes: 2017-2019

Historic Other Working Capital Changes for Astria Therapeutics (ATXS) over the last 3 years, with Dec 2019 value amounting to $618,000.

  • Astria Therapeutics' Other Working Capital Changes rose 984.21% to $618,000 in Q4 2019 from the same period last year, while for Dec 2019 it was $1.3 million, marking a year-over-year increase of 628.25%. This contributed to the annual value of $1.3 million for FY2024, which is 72.46% down from last year.
  • According to the latest figures from Q4 2019, Astria Therapeutics' Other Working Capital Changes is $618,000, which was down 45.16% from $1.1 million recorded in Q3 2019.
  • In the past 5 years, Astria Therapeutics' Other Working Capital Changes registered a high of $1.1 million during Q3 2019, and its lowest value of -$436,000 during Q2 2018.
  • Its 3-year average for Other Working Capital Changes is $129,917, with a median of $7,000 in 2017.
  • The largest annual percentage gain for Astria Therapeutics' Other Working Capital Changes in the last 5 years was 1,240.00% (2018), contrasted with its biggest fall of 1,178.95% (2018).
  • Astria Therapeutics' Other Working Capital Changes (Quarterly) stood at -$5,000 in 2017, then spiked by 1,240.00% to $57,000 in 2018, then skyrocketed by 984.21% to $618,000 in 2019.
  • Its last three reported values are $618,000 in Q4 2019, $1.1 million for Q3 2019, and -$102,000 during Q2 2019.